FDA's Trazodone Facility Worries Fixed: Labopharm

Law360, New York (October 8, 2009, 5:43 PM EDT) -- Labopharm Inc. has announced that the producer of the active ingredient in the pharmaceutical company's antidepressant trazodone has fixed manufacturing problems identified by the U.S. Food and Drug Administration, moving the product a step closer to agency approval in 2010.

Italian manufacturer Angelini informed Canada-based Labopharm that it received a letter from the FDA confirming that it had sufficiently addressed all the concerns the agency raised after inspecting the manufacturing facility in June and July, Labopharm said in a statement Wednesday.

In the letter, the FDA...
To view the full article, register now.